Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay Protocols
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay Protocols
Authors
Keywords
-
Journal
SLAS Discovery
Volume 22, Issue 2, Pages 125-134
Publisher
SAGE Publications
Online
2016-10-12
DOI
10.1177/1087057116673796
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade
- (2016) Manu De Rycker et al. PLoS Neglected Tropical Diseases
- Pentamidine exerts in vitro and in vivo anti Trypanosoma cruzi activity and inhibits the polyamine transport in Trypanosoma cruzi
- (2014) María V. Díaz et al. ACTA TROPICA
- Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments
- (2014) Daniel Michał Kamiński EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
- (2014) Israel Molina et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Image-Based Algorithm for Precise and Accurate High Throughput Assessment of Drug Activity against the Human Parasite Trypanosoma cruzi
- (2014) Seunghyun Moon et al. PLoS One
- Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
- (2014) Carolina B. Moraes et al. Scientific Reports
- Stage-Regulated GFP Expression in Trypanosoma cruzi: Applications from Host-Parasite Interactions to Drug Screening
- (2013) Rafael Luis Kessler et al. PLoS One
- Analogues of Fenarimol Are Potent Inhibitors of Trypanosoma cruzi and Are Efficacious in a Murine Model of Chagas Disease
- (2012) Martine Keenan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Methodological advances in drug discovery for Chagas disease
- (2011) Juan M Bustamante et al. Expert Opinion on Drug Discovery
- SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
- (2011) Robert T. Jacobs et al. PLoS Neglected Tropical Diseases
- Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine
- (2010) V. Yardley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
- (2010) J. C. Engel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chagas disease
- (2010) Anis Rassi et al. LANCET
- In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
- (2010) Adriana M. C. Canavaci et al. PLoS Neglected Tropical Diseases
- Chagas disease in Spain, the United States and other non-endemic countries
- (2009) Joaquim Gascon et al. ACTA TROPICA
- Cellular Transport and Lipid Interactions of Miltefosine
- (2009) Gillian Barratt et al. CURRENT DRUG METABOLISM
- Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities
- (2009) Rodolfo Viotti et al. Expert Review of Anti-Infective Therapy
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started